Quarterly Activity Report – Quarter Ending 30 September 2022

 Highlights: Imagion presented prostate cancer research data at World Molecular Imaging Conference (WMIC)  Receipt of $2.5 million R&D tax incentive…


Imagion Biosystems receives AU$2.5 million in R&D tax incentives

ASX Announcement: MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is…


The Market Herald Interview Discussing First-of-its-Kind Magnetic Imaging Technology

We recently announced that our MagSense® diagnostic technology has the potential to target prostate cancer tumors, making this the second cancer type the…


Fear and Greed Podcast Discussing Precise Imaging Solutions to Detect Cancers

Our Chairman and CEO Bob Proulx was a recent guest at the Fear and Greed podcast, discussing our pursuit of better, more precise imaging solutions to detect…


2022 Switzer Small & Micro Cap Conference Presentation

Imagion Bio CEO, Robert Proulx, presents company information to investors at the 2022 Switzer Small & Micro Cap Conference in September. Video Transcript:…


Imagion to Present Prostate Cancer Research Data at WMIC 2022

Imagion to present prostate cancer research data at World Molecular Imaging Congress MagSense® molecular imaging agent shows high specificity and selectivity……


Half-Year Results for the First Half of 2022 and Appendix 4D

Today, we released our Appendix 4D and Half-Year Financial Report for the half-year ending 30 June 2022 to the ASX. 1H2022 Highlights: MagSense® HER2 breast…


30 June 2022 4C screen shot

Quarterly Activity Report and Appendix 4C for 30 June 2022

Imagion has released the Quarterly Activity Report and Appendix 4C for the period ending on 30 June 2022. The announcement highlights: MagSense® HER2 imaging…


Results of 2022 Annual General Meeting

In accordance with ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act 2001, Imagion Biosystems Limited advises the results of its Annual…


Presentation Visuals from 25th May 2022 Annual General Meeting

The presentation visuals from the 25th May 2022 Annual General Meeting are now available. You can find the 2022 AGM Investor Presentation here.    …